Clincosm LogoSign in Get a demo

pancreatic acinar cell carcinoma

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

Not yet recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Nab paclitaxel
  • +5 more
  • (no location specified)
Oct 30, 2023

Pancreatic Acinar Cell Carcinoma Trial run by the National Cancer Institute (NCI) (Olaparib)

Recruiting
  • Pancreatic Acinar Cell Carcinoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma, Pancreatic Squamous Cell Carcinoma Trial in United States

Recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Biospecimen Collection
  • +4 more
  • Anchorage, Alaska
  • +357 more
Jan 28, 2023

Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

Recruiting
  • Pancreatic Adenocarcinoma Metastatic
  • +14 more
  • Boston, Massachusetts
  • +1 more
Dec 6, 2022

Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in

Active, not recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +8 more
  • 3-Dimensional Conformal Radiation Therapy
  • +8 more
  • Mobile, Alabama
  • +697 more
Nov 16, 2022

Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen

Recruiting
  • Acinar Cell Carcinoma
  • +93 more
  • Biospecimen Collection
  • +2 more
  • Birmingham, Alabama
  • +998 more
Aug 23, 2022

Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma Trial in New

Active, not recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • +4 more
  • Falimarev
  • +3 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 4, 2022

Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in United States (drug,

Completed
Has Results
  • Pancreatic Acinar Cell Carcinoma
  • +3 more
  • Washington, District of Columbia
  • +5 more
Feb 8, 2018

Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in United States (Akt

Completed
Has Results
  • Pancreatic Acinar Cell Carcinoma
  • +3 more
  • Akt Inhibitor MK2206
  • +3 more
  • Tucson, Arizona
  • +533 more
Feb 10, 2016